Global Microfluidic Devices Market

Microfluidic Devices Market Size, Share, Growth Analysis, By Type(Microfluidic Chips, Microfluidic Sensors, Microfluidic Pumps, Microfluidic Valves and Others.), By Application(Pharmaceutical and Life Sciences, Diagnostics, Chemical and Environmental Analysis, Food and Agriculture and Others.), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35H2120 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 65 | Figures: 75

Microfluidic Devices Market News

  • In March 2023, Agilent Technologies announced the launch of its new Bioanalyzer 2100 System. This system is designed to provide a complete solution for DNA sequencing, gene expression analysis, and protein analysis. [March 2023, Agilent Technologies]
  • In February 2023, Danaher Corporation announced the acquisition of Fluidigm Corporation. Fluidigm is a leading manufacturer of microfluidic devices for use in life sciences research and clinical diagnostics. [February 2023, Danaher Corporation]
  • In January 2023, General Electric Company announced the launch of its new Edison microfluidic platform. This platform is designed to enable rapid prototyping and manufacturing of microfluidic devices. [January 2023, General Electric Company]
  • In December 2022, PerkinElmer Inc. announced the launch of its new InForm® Xtra Platform. This platform is designed to provide a complete solution for clinical diagnostics, including sample preparation, diagnostics, and drug discovery. [December 2022, PerkinElmer Inc.]
  • In November 2022, Thermo Fisher Scientific Inc. announced the launch of its new BioMérieux Vitek MS System. This system is designed to provide a complete solution for microbiology testing, including identification, antimicrobial susceptibility testing, and antibiotic resistance testing. [November 2022, Thermo Fisher Scientific Inc.]
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Microfluidic Devices Market size was valued at USD 82.14 Billion in 2023 and is poised to grow from USD 96.35 Billion in 2024 to USD 345.35 Billion by 2032, growing at a CAGR of 17.3% during the forecast period (2025-2032).

The competitive landscape is shaped by factors such as product innovation, quality, pricing, regulatory compliance, and customer relationships. Established companies with a strong market presence leverage their experience, brand reputation, and extensive distribution networks to maintain a competitive edge. These players often invest significantly in research and development to introduce new and advanced microfluidic devices that meet the evolving needs of customers. 'Danaher Corporation (US)', 'Thermo Fisher Scientific Inc. (US)', 'Agilent Technologies, Inc. (US)', 'PerkinElmer, Inc. (US)', 'Bio-Rad Laboratories, Inc. (US)', 'Roche Diagnostics (Switzerland)', 'Becton, Dickinson and Company (US)', 'Siemens Healthineers AG (Germany)', 'Fluidigm Corporation (US)', 'Dolomite Microfluidics (UK)', 'Abbott Laboratories (US)', 'Cepheid (US)', 'QIAGEN N.V. (Netherlands)', 'Bio-Rad Laboratories, Inc. (US)', 'Microfluidic ChipShop GmbH (Germany)', 'Illumina, Inc. (US)', 'Cellix Ltd. (Ireland)', 'Agilent Technologies, Inc. (US)', 'RainDance Technologies (US)', 'Dolomite Bio Ltd. (United Kingdom)'

There is an increasing market demand for compact and portable devices across various industries, including healthcare, pharmaceuticals, and biotechnology. Microfluidic devices are well-suited to meet this demand due to their small size, reduced sample volumes, and integration of multiple functions. The ability to perform complex laboratory processes on a small scale, along with the convenience of portability and on-site analysis capabilities, are driving the adoption of microfluidic devices in different applications and contributing to market growth.

Increasing adoption of point-of-care testing (POCT) applications: Point-of-care testing refers to diagnostic testing conducted at or near the patient, providing immediate results that facilitate quick decision-making by healthcare professionals. Microfluidic devices have gained significant traction in POCT applications due to their ability to handle small sample volumes, enable rapid analysis, and offer portability and ease of use. These devices are utilized in various healthcare settings, including hospitals, clinics, and home care settings, allowing for faster diagnosis and treatment decisions. The trend towards POCT is driven by the need for rapid and accurate diagnostic information, particularly in emergency and critical care situations.

North America holds a significant share in the Tablet Coatings market due to several factors. The region has a well-established pharmaceutical and healthcare infrastructure, along with a strong presence of key pharmaceutical manufacturers. The demand for tablet coatings in North America is driven by factors such as increasing research and development activities, high healthcare expenditure, and the presence of advanced pharmaceutical manufacturing technologies. Additionally, the region has a higher adoption rate of innovative coating technologies and a focus on quality control and regulatory compliance, further contributing to its dominance in the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Microfluidic Devices Market

Report ID: SQMIG35H2120

$5,300
BUY NOW GET FREE SAMPLE